Cilvas-M Tablet ER Substitute

Cilvas-M Tablet ER contains Cilnidipine and Metoprolol succinate. Cilnidipine acts on the calcium channels of the blood vessels which suppress the contraction of blood vessels and promote smooth blood flow. Metoprolol succinate lowers heart rate and facilitates simpler blood circulation throughout the body. Thus, Cilvas-M Tablet ER helps treat hypertension.

Cilvas-M Tablet ER may cause a slow heart rate (bradycardia). A minor fluctuation should not be a worry; however, if a slow heart rate continues or you begin to feel unwell, speak with your doctor.

The workload on the heart and arteries is increased by high blood pressure. It could harm the blood vessels in the heart, brain, and kidneys, which could lead to a stroke, heart failure, or renal failure if left untreated. The likelihood of heart attacks rises with hypertension. Anti-hypertensives like Cilvas-M Tablet ER are therefore used to bring blood pressure to a normal level, lowering the risk of developing certain disorders.

Please do not stop taking Cilvas-M Tablet ER without consulting your doctor as abrupt stopping may lead to a rise in blood pressure. To treat your condition effectually, continue taking Cilvas-M Tablet ER for as long as your doctor has prescribed it to you. Do not be reluctant to speak with your doctor if you experience any difficulty while taking Cilvas-M Tablet ER.

Orthostatic hypotension could be a side-effect of Cilvas-M Tablet ER. Orthostatic hypotension is a sudden lowering in blood pressure leading to dizziness on standing. If you experience this condition, do not try to stand up suddenly or start walking, instead lie down and get up slowly only when you feel better. Your doctor may monitor your blood pressure levels regularly while you are on treatment with this medicine, to avoid unpleasant events.